Participated · Seed · Feb 2026

Oska Health offers an AI-supported coaching platform that pairs certified health coaches with digital therapy tools to deliver continuous care for high-risk, multimorbid patients suffering from chronic kidney disease, diabetes, hypertension, and other long-term conditions. Through video calls, chat, and a dedicated app, coaches translate physicians’ recommendations into day-to-day actions, aiming to boost medication adherence, strengthen health literacy, and lower avoidable hospitalisations. The company’s proprietary AI augments care teams by triaging patient needs and reducing administrative workload, making personalised chronic-care support scalable. Operating for more than three years, Oska Health has demonstrated its ability to keep patients engaged between medical appointments. The newly raised capital will fund further expansion of its AI infrastructure and broaden access to its hybrid care model across Europe. Financial details beyond the recent seed round have not been disclosed.

Led · Seed · Feb 2026

Founded in 2024 by former Unibail-Rodamco-Westfield executives Sébastien Renault and Sakina Elkassouani, Newable builds software-driven products and services aimed at accelerating the energetic decarbonization of commercial real-estate assets. The platform analyzes building portfolios to pinpoint the properties with the highest potential for carbon reduction and value creation, then recommends the most suitable energy solutions. Its target customers are institutional and corporate owners of large tertiary (commercial) real-estate portfolios seeking to meet tightening regulatory requirements such as France’s ‘décret tertiaire’. Early traction is benefiting from this regulatory momentum, and the founders position the company as a one-stop partner for large-scale portfolio decarbonization. The startup is headquartered in Bordeaux and intends to use newly secured capital to speed product development and market expansion. The recent €4 million pre-seed raise represents its first external funding disclosed to date.

Participated · Series B · Feb 2026

Tem operates two complementary businesses: Rosso, an AI-driven transaction engine that pairs electricity suppliers with buyers, and RED, a "neo-utility" that uses Rosso to sell power directly to customers. By collapsing the many intermediaries in traditional energy trading, its machine-learning and LLM models aim to bring end-user prices closer to wholesale rates, promising up to 30% savings. The company has already signed more than 2,600 business customers in the U.K., including Boohoo Group, Fever-Tree and Newcastle United FC, and focuses on renewable and distributed generation assets that suit its algorithms. Tem intentionally built RED first after legacy utilities showed little interest in licensing Rosso, but it plans to open the platform to other utilities once scale is proven. Management says the business is currently profitable on its own but is pursuing rapid growth with an eye toward a future IPO. Fresh capital will fund geographic expansion to Australia and the U.S., beginning in Texas. A recent Series B financing values Tem at over $300 million, underscoring investor confidence in its infrastructure-as-a-service approach to energy markets.

Participated · Series A · Jan 2026

Headquartered in Hamburg, one.five offers an AI-driven solution that converts technical performance data, regulatory constraints, and consumer preferences into precise requirement profiles for new packaging materials. This data-centric approach is designed to cut R&D waste and shorten time-to-market for sustainable paper-based packaging. The company was founded by Martin Weber, former CFO of vertical-farming unicorn Infarm, and Claire Hae-Min Gusko. Early commercial traction includes collaborations with paper manufacturers Starkraft (a Zellstoff Pöls AG unit) and Grünperga Papier, while it is also cultivating partnerships with converters and global FMCG brands. The recently secured Series A funding will finance further platform development and international operational expansion. Although no revenue or user numbers were disclosed, the company positions itself as a critical technology layer within the packaging supply chain, aiming to deliver market-ready, regulation-compliant materials more efficiently.

Participated · Seed · Nov 2025

Mirantus Health digitises and decentralises ophthalmic pre-screenings through its software platform “mira,” which equips optician shops to capture retina images, intra-ocular pressure, slit-lamp photos, refraction data and visual-acuity tests. The data are transmitted to a pool of ophthalmologists who return a written assessment within 24–48 hours, flagging any abnormalities that warrant a full medical examination. The company already serves more than 200 locations across Germany and supports scheduling through a network of over 400 partner ophthalmologists, relieving pressure on traditional practices. By 2027 Mirantus aims to scale the service to more than 1,000 sites throughout Germany, Austria and Switzerland. The solution targets growing shortages in eye-care caused by an ageing specialist workforce, with roughly 30 % of German ophthalmologists nearing retirement. Revenue metrics were not disclosed, but the firm will use fresh capital to expand geographically and enhance its software. Its value proposition centres on early detection, reduced wait times for patients and lower long-term costs for the healthcare system.